Arrayjet Broadens Microarray Offerings

Arrayjet has launched custom microarray services as an extension of its product provision base. Since entering the microarray market in 2005 with the first of its suite of four microarrayers based on non-contact technology., the company has successfully sold over forty instruments worldwide to organisations such as The Roslin Institute, The Medical Research Council of Great Britain, EMBL, Cornell University, Millipore, Novartis and CalTech. Duncan Hall, Arrayjet’s Commercial Director, said: ”To date, Arrayjet has been focused on delivering its core microarray printing products based on its unique inkjet technology. Throughout this time we have had numerous enquiries from researchers who have wanted to access our printing technology and microarray development expertise on a ‘usage’ basis.

We are now addressing this demand and have already signed up our first customers.”

“We will be investing considerable resources in our custom microarray services, which we believe will be the broadest and most flexible available. Indeed we will also offer a hybrid business model: customers can initially work with us on assay development and custom microarray printing, before electing to take control of production in their own facility when they are ready; Arrayjet will then transfer the entire production solution as part of the service.”